INTRODUCTION
Protein kinase C (PKC) is a multi-gene family of serine/threonine kinase that plays key roles in the regulation of signal transduction and cellular function in various cell-types/tissues [1] [2] [3] [4] . PKC forms a multi-gene family and at least 10 PKC isoforms have been identified that differ in primary structure, tissue distribution, subcellular localization and substrate specificity [1] [2] [3] [4] . These isoforms can be sub-grouped into three subfamilies. Members of the first family (include PKCα, βI, βII and γ) are regulated by Ca 2+ , diacylglycerol (DAG) and phospholipids, and are known as Ca 2+ -dependent PKCs [or classical PKCs (cPKC)]; members of the second family (include PKCδ,ε, η and θ) have phospholipid-dependent but Ca 2+ -independent activation mechanism, and are known as Ca 2+ -independent PKCs or novel PKCs (nPKC); members of the third family (include PKCζ and ι/λ) are not regulated by either intracellular Ca 2+ concentration or phospholipid and their activity are maintained by other mechanisms (e.g. by protein-protein interactions), and are known as atypical PKCs (aPKC). Intracellular localizations of these individual isoforms are important for regulation of isoform-specific enzyme activity and substrate specificity [2, 3] . Since the stimulation of G q PCRs such as α 1 -adrenoceptor (α 1 -AR), endothelin-1 receptor or angiotensin II receptor can generate DAG and also mobilize cytosolic Ca 2+ elevation by releasing Ca 2+ from the intracellular stores by stimulating inositol trisphosphate (IP 3 ) receptors [5] , cPKC and nPKC isoforms, but not aPKC are located downstream of G q PCR signaling pathways. Growing evidence suggests that stimulation of different G q PCRs exhibits receptor-specific pattern of activation and translocation of PKC isoforms [3] . However, since prior research investigating PKC translocation were mostly conducted using general PKC activators, such as phorbol esters [3] , the knowledge of receptor-specific regulation of PKC-isoform activation/translocation is still incomplete.
One of G q PCRs, α 1 -AR, is stimulated by catecholamines (norepinephrine and epinephrine) [6] [7] [8] [9] . α 1 -AR is expressed in variety of human tissue [10] and α 1 -AR stimulation has been shown to play important roles in cellular physiological functions, such as 1) regulation of smooth muscle contraction and tone in vascular system [9] , prostate, urethra, bladder [11] , uterine [12] and iris [13] , 2) myocardial inotropy and chronotropy [14] , 3) hepatic glucose metabolism [15] , 4) water secretion at salivary gland [16] and 5) neurotransmission in central nerve system [9] . In addition, chronic α 1 -AR stimulation leads to pathophysiological responses in the various cells/tissues via both cPKC and nPKC isoform signaling pathways, including cardiac hypertrophy [17, 18] , hypertension and atherosclerosis [19, 20] in cardiovascular system and portal hypertension and fibrosis in liver [21] . Despite strong interest in the mechanism underlying α 1 -AR signaling-mediated pathology, especially in cardiovascular system, little is known about the molecular mechanisms for the PKC isoform-specific kinetics of activation and translocation.
Here we examined the isoform-specific dynamic translocation of PKC in live HEK293T cells by α 1 -AR stimulation using GFP-tagged PKC isoforms, especially monitoring their translocation to the plasma membrane (PM). We tested six PKC isoforms (α, βI, βII, δ, ε and ζ) in this study which are endogenously expressed in this cell line [22] . Our results show that PKCα, βI, βII and ε are able to be translocated to the PM upon α 1 -AR stimulation, while PKCδ did not show any significant PM translocation upon α 1 -ARS, although all isoforms are translocated to PM by a common PKC activator, phorbol 12-myristate 13-acetate (PMA) with a relatively slow time course. Our data suggest that PKCα, βI, βII and ε activation may underlie physiological responses of α 1 -AR signaling. In addition, due to a prolonged retention of PKCβI, PKCβII and PKCε at PM by α 1 -AR stimulation, these isoforms may be particularly important for the cellular pathophysiology in various cell types including cardiovascular system during chronic α 1 -AR stimulation.
MATERIAL AND METHODS
An expanded Material and methods section is available in the online supplementary file.
Live cell imaging
HEK293T cells and stable HEK293T cell line [23] carrying HA-tagged α 1A -AR (Supplementary Fig.1 ) were transfected with GFP-tagged and/or DsRed2-tagged PKC isoforms and used for experiments 48 hours after transfection [24, 25] . Time-dependent changes in localization of PKC isoforms by either phenylephrine (Phe) or PMA stimulation in HEK293T cells was measured using laser scanning confocal microscopy (Olympus, Tokyo Japan) without fixation at room temperature [25, 26] . PM localization of PKC isoform was quantified by line scan intensity measurements through each cell beginning in the cytosol region (avoiding the nucleus area) and ending at the cell periphery. Translocation of each PKC isoform was evaluated by fluorescence intensity ratio between membrane and cytosolic region (membrane/cytosol ratio: M/C ratio) [25, 26] .
Statistical Analysis
All results are shown as mean ± standard error (SE). One-way ANOVA followed by Dunnet's test (for multiple comparison) and paired-T-test (for two-group comparison) were done with the significance level set at P<0.05.
RESULTS

PKCα transiently translocates to the PM in response to α 1 -ARS
We co-expressed a GFP-tagged Ca 2+ -dependent PKC isoform PKCα with α 1A -AR in HEK293T cells, stimulated the cells with a specific α 1 -AR agonist 100 μM Phe, and observed time-dependent changes in the subcellular localization of PKCα upon Phe stimulation (Fig.1A ). Prior to stimulation (0 min), PKCα-GFP mainly localized in cytosol, with no nuclear localization ( Fig.1A and B) . After Phe stimulation PKCα-GFP rapidly translocated to the cell membrane (less than 30s) and gradually returned to cytosol. PKCα localization was restored within 5 min despite continuous Phe stimulation. This PKC translocation was completely blocked by the α 1 -AR-selective antagonist, 1 μM prazosin ( Fig.1B and Supplementary Fig.2 ). We also tested the effect of PKC activator PMA on PKCα-GFP translocation. PKCα-GFP showed relatively slower translocation to PM by PMA treatment compared to Phe (Fig.1B and Supplementary Fig.2 ).
As a control experiment, we co-expressed GFP with α 1A -AR in HEK293 cells and confirmed that GFP localization did not alter by Phe stimulation (Supplementary Fig.3 ).
PKCβI and PKCβII translocate to the PM in response to α 1 -ARS
We next co-expressed other Ca 2+ -dependent PKC isoforms (GFP-tagged PKCβI or PKCβII) with α 1A -AR in HEK293T cells and observed time-dependent changes in the subcellular localization of each PKC isoform by Phe (Fig.1C to F) . Prior to stimulation, both PKCβI and PKCβII were localized in the cytosol, with no nuclear localization. Phe stimulation induced translocation of both PKCβI and PKCβII to the PM rapidly (after 30 sec) and PM localization was maintained throughout the course of the Phe application. Both PKCβI-GFP and PKCβII-GFP showed slower translocation to the PM by a PKC activator PMA treatment compared to Phe stimulation ( Fig.1D and F) , which is a similar time course as the one observed in PKCα (see Fig.1B ). Interestingly, magnitude of PKCβII translocation by Phe stimulation was larger than that of PKCβI ( Fig.1D and F) .
To confirm the different translocation dynamics of PKCβI and βII by either Phe or PMA, we stimulated cells expressing both GFP-and DsRed2-tagged PKCβs. To normalize the magnitude of signal inputs (namely receptor signals via the G q -protein) between the individual cells, HEK293T cells stably overexpressing α 1A -AR (α 1A -AR-HEK293T cells) were used for these experiments (Supplementary Fig.1 ). First, we confirmed that GFP-and DsRed2-tagged PKCβII showed similar translocation profiles under Phe or PMA stimulations in α 1A -AR-HEK293T ( Fig.1G and H) . Using α 1A -AR-HEK293T cells coexpressing PKCβI-GFP and DsRed2-PKCβII, we next confirmed that magnitude of PKCβII translocation by Phe stimulation was significantly larger than that of PKCβI ( Fig.1I and J) . In contrast, PMA stimulation induces larger translocation of PKCβI than that of PKCβII (Fig.1J) .
PKCε but not PKCδ translocate to the PM in response to α 1 -ARS
We next tested whether Ca 2+ -independent PKC isoforms translocates to the PM by α 1 -ARS. We co-expressed GFP-tagged PKCδ or PKCε with α 1A -AR in HEK293T cells and observed time-dependent changes in the subcellular localization of these PKC isoforms upon Phe application. Prior to stimulation, PKCδ was localized in cytosol ( Fig.2A) . Some cells have strong punctuated fluorescence areas around the nucleus ( Supplementary Fig.4) . No significant time-dependent changes were observed in the subcellular localization of PKCδ by Phe treatment ( Fig.2A and B) . As a positive control, we observed significant translocation of PKCδ in response to treatment with PMA in the same cells (Fig2A and B) . After PMA treatment, PKCδ was translocated from the cytosol to the PM and also to the nuclear membrane ( Fig.2A, 2B and supplementary Fig.4) . We also confirmed the lack of GFP-tagged PKCδ translocation by Phe using α 1A -AR-HEK293T cells co-transfected with DsRed2-PKCβII (Fig.2C) . In contrast, PKCε was significantly translocated from the cytosol to the PM 3 min after Phe stimulation and its PM localization was maintained during the course of the Phe application ( Fig.2D and E) . Magnitude of GFP-tagged PKCε translocation by 10-min Phe stimulation was larger than that in PKC βI and also reached to the similar level of that in PKCβII (see Fig.1D and F) . To quantitatively compare the translocation levels of PKCε and PKCβI by Phe, we stimulated α 1A -AR-HEK293T cells expressing both GFP-PKCε and DsRed2-tagged PKCβI. The magnitude of PKCε translocation was consistently higher after Phe stimulation than that of PKCβI when measured in the same cell (Fig.2F, left) . In contrast, PMA stimulation induces similar translocation profiles in these PKC isoforms (Fig.2F, right) .
PKCζ does not show any translocation in response to α 1 -ARS
Finally, we tested whether DAG-and PMA-insensitive isoform (aPKC) change its subcellular localization in response to α 1 -ARS. We co-expressed one of the aPKC isoform PKCζ in HEK293 cells and monitored time-dependent changes in the subcellular localization of PKCζ upon Phe application. Prior to stimulation, PKCζ was localized in cytosol and no nuclear localization was observed (Fig. 3) . There was no significant timedependent change in the subcellular localization of PKCζ by α 1 -ARS.
DISCUSSION
In this study, we examined the translocation profiles of PKC isoforms to the PM in live cells expressing GFP-and DsRed2-tagged PKC isoforms upon α 1 -AR stimulation. One advantage of using fluorescence protein-tagged PKC expression system is the ability to obtain more precise and quantitative spatiotemporal kinetics information on PKC activation and translocation profiles compared to classical methods, including Western blotting of fractionated proteins and the immunocytochemstry of fixed cells using isoform-specific antibodies [2, 3] . Our results clearly indicate that each PKC isoform shows a different spatiotemporal pattern of translocation under α 1 -ARS (Fig. 4) . We found the significant translocation of Ca 2+ -dependent PKCs (α, βI and βII) and one Ca 2+ -dependent PKC (PKCε) to the PM in response to α 1 -AR stimulation, which may underlie acute responses of α 1 -AR signaling at the PM. However, subcellular localization of another Ca 2+ -dependent PKC, PKCδ was not significantly modified by α 1 -ARS in the current experiments, despite showing a strong response to PMA (Fig.2) .
Physiological and pathophysiological functions of each PKC isoform are diverse even though their substrate specificity is low and multiple isoforms are expressed in each celltype [2, 3] . For instance, in the human myocardium, PKCα was the most abundant isoform present [19; 20] and PKCα activation has been linked to heart failure, hypertrophy and diabetes [21] [22] [23] [24] [25] [26] [27] . However, subsequent studies in genetic models of PKCα overexpression or knockout in mice failed to yield significant role of PKCα in generating hypertrophy to PKCα, identifying a more predominant role for PKCα in the regulation of cardiac contraction [28] . On the other hand, expression level of Ca 2+ -dependent PKCβ increases in the cardiovascular system during disease states. PKCβ activation has been linked to increased vascular inflammation and atherosclerosis [29] . In addition, genetic models showed that PKCβ expression is not necessary for the development of cardiac hypertrophy nor does its absence attenuate the hypertrophic response [30] . PKCε has been suggested to have a protective role in myocardial ischemia-reperfusion injury [31] and arrhythmias [32] .
Moreover, the use of specific PKC isoenzyme blockers may lead to novel treatments for heart failure [35; 36] and also for cancers [33] and Alzheimer's disease [34] . Targeting PKC to the PM is crucial for the phosphorylation of membrane-associated substrates, including ion-channel and transporter proteins [27] . PMA is one of the well recognized activators of DAG-sensitive PKC subfamilies and is frequently used to mimic G q PCR signaling for investigating the effect of PKC translocation [2, 3] to the PM, including in the studies for the regulation of ion channel function. However, we showed in live cells that the translocation kinetics of PKCs are largely different in response to either PMA treatment or receptor stimulation. First, α 1 -AR stimulation by Phe initiates PKC translocation much faster than PMA started (≅ 30 sec after stimulation) . Second, while G q PCR-mediated PKCα translocation to the PM is transient, PMA treatment induces this isoform to be retained at the PM (Figs.1 and 4) . Finally, isoform-specificity is also different between G q PCR and PMA responses; PMA caused sustained translocation of all DAG-sensitive isoforms tested to the PM (Figs.1 and 2) , while α 1 -AR-mediated PKCδ translocation to the PM was not observed (Fig.2) . This observation is consistent with previous data showing that connexin43, a gap junction channel protein, can be phosphorylated by PMA treatment through both PKCδ and PKCε [28, 29] , but PKCδ does not likely phosphorylate Connexin43 under G q PCR stimulation [30] . Thus, these results indicate that great caution is required when extending the results obtained with general PKC activators to PKC isoform activation by more physiological signaling pathways.
While we did not observe significant PKCδ translocation by α 1 -AR stimulation from cytosol to the PM using transfected PKCδ-GFP, our data does not exclude the possibility that PKCδ can be activated by α 1 -AR stimulation and translocated to the other cellular compartments including mitochondria and nucleus. For instance, Newton and colleagues detected a relatively small but significant PKCδ translocation to the outer mitochondrial membrane (OMM) after the application of a phorbol ester using fluorescence resonance energy (FRET) by generating an OMM-targeted [31] CFP (mt-CFP) and PKCδ-GFP [32] . They also confirmed that PKCδ activity was increased at the OMM upon phorbol-ester stimulation, using the OMM-targeted FRET-based PKCδ kinase activity reporter. Taken together, the data suggest that G q PCR stimulation may activate and translocate PKCδ to other intracellular compartments, but not to PM.
In summary, we showed that α 1 -AR induces PKCα, PKCβ and PKCε translocation to the PM, but not PKCδ and PKCζ by tracking the subcellular localization of transfected GFPtagged PKC after Phe stimulation. In addition, we found that kinetics of α 1 -AR-mediated activation of PKCs is isoform-specific. Our data suggests that activation of PKCα, PKCβ and PKCε may underlie physiological and pathophysiological responses of α 1 -AR signaling for the phosphorylation of PM-localized proteins such as ion channels and transporters.
Highlights
• Isoform-specific translocation pattern of PKC was observed in live cells.
• PKCα, βI, βII, and ε translocates to plasma membrane by α 1 -adrenergic stimulation.
• PKCδ did not show any translocation to plasma membrane by α 1 -adrenergic stimulation.
• PKC translocation kinetics were different between PMA and α 1 -adrenergic stimulation.
• PKCα, βI, βII and ε may underlie physiological responses of α 1 -adrenergic signaling. 
